Tumors as chaotic attractors.

Malignant tumor growth, progression and evolution share several of the features associated with strange attractors, a special type of dynamical behavior of non-linear systems. In this framework, the genetic instability of tumor cells represents a local-scale driving force for instability that lets the tumor evolve with time, while selective pressures discarding inefficient cell clones play the role of a dissipative process, providing the tumor with global stability and robustness with respect to perturbations. This setup induces global stability combined with local instability, and is in our opinion the real source of tumor robustness and plasticity, and ultimately the origin of the remarkable resistance of many tumors to anti-cancer therapies. A scientific program taking into consideration the vision of tumors as strange attractors requires the development of experimental and computational tools to link the micro- and mesoscopic perspectives of tumor biology. We here develop the idea of a tumor as a dynamical system, sharing characteristics with strange attractors and investigate several features of such systems, including: (a) local instability combined with global stability, a property inherent to the tremendous non-linearity of the biochemical regulatory circuits governing the individual fate and the interactions between tumor cells; (b) self-similarity at different levels; (c) and strong sensitivity to initial conditions in the composition and features of the tumor and its microenvironment.

[1]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[2]  Luke A. Gilbert,et al.  DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.

[3]  R. Solé,et al.  Metapopulation dynamics and spatial heterogeneity in cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[5]  R. Gatenby A change of strategy in the war on cancer , 2009, Nature.

[6]  Olaf Wolkenhauer,et al.  Analysis of cell adhesion during early stages of colon cancer based on an extended multi-valued logic approach. , 2012, Molecular bioSystems.

[7]  W. Schubert,et al.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.

[8]  L. Glass,et al.  Chaos in multi-looped negative feedback systems. , 1990, Journal of theoretical biology.

[9]  Temple He,et al.  Chaos and noise. , 2012, Chaos.

[10]  Lars Folke Olsen,et al.  Biochemical oscillations and cellular rhythms: The molecular bases of periodic and chaotic behaviour: Albert Goldbeter. Cambridge University Press, Cambridge, 1996. $99.95 (cloth), 605 + xxiv pp , 1997 .

[11]  David Liao,et al.  Conceptualizing a tool to optimize therapy based on dynamic heterogeneity , 2012, Physical biology.

[12]  A. Brú,et al.  The universal dynamics of tumor growth. , 2003, Biophysical journal.

[13]  Takeshi Takahashi,et al.  Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma , 2013, International journal of cancer.

[14]  A. Dalgleish,et al.  The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. , 1999, QJM : monthly journal of the Association of Physicians.

[15]  Stephanie Forrest,et al.  Modeling Somatic Evolution in Tumorigenesis , 2006, PLoS Comput. Biol..

[16]  O. Wolkenhauer,et al.  Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network. , 2013, Cancer research.

[17]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[18]  A. Kolmogoroff Über die analytischen Methoden in der Wahrscheinlichkeitsrechnung , 1931 .

[19]  Chaos In Systems With Noise: (2nd Edition) , 1990 .

[20]  M. Yamakuchi,et al.  miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.

[21]  Yan Liu,et al.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. , 2012, The Journal of clinical investigation.

[22]  Olaf Wolkenhauer,et al.  MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biology. , 2013, Advances in experimental medicine and biology.

[23]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[24]  I. Witz Tumor-microenvironment interactions: dangerous liaisons. , 2008, Advances in cancer research.

[25]  F. Takens,et al.  On the nature of turbulence , 1971 .

[26]  J. Timmer,et al.  Design principles of a bacterial signalling network , 2005, Nature.

[27]  M. Cross,et al.  Pattern formation outside of equilibrium , 1993 .

[28]  Katherine C. Chen,et al.  Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. , 2003, Current opinion in cell biology.

[29]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[30]  A. Oudenaarden,et al.  Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences , 2008, Cell.

[31]  C. Auffray,et al.  The road from systems biology to systems medicine , 2013, Pediatric Research.

[32]  C. Holterman,et al.  ETS-1 oncogenic activity mediated by transforming growth factor alpha. , 2010, Cancer research.

[33]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[34]  C. Iacobuzio-Donahue,et al.  Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies , 2012, Cell.

[35]  A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer , 2011, Molecular Cancer Therapeutics.

[36]  Olaf Wolkenhauer,et al.  Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. , 2010, Cancer research.

[37]  Hiroaki Kitano,et al.  Cancer robustness: Tumour tactics , 2003, Nature.

[38]  E. Ahmed Fractals and chaos in cancer models , 1993 .

[39]  Olaf Wolkenhauer,et al.  A system biology approach to understand functional activity of cell communication systems. , 2008, Methods in cell biology.

[40]  Ana M Soto,et al.  Theories of carcinogenesis: an emerging perspective. , 2008, Seminars in cancer biology.

[41]  K. Loeb,et al.  Significance of multiple mutations in cancer. , 2000, Carcinogenesis.

[42]  Hartmut Dickhaus,et al.  Bridging the scales: semantic integration of quantitative SBML in graphical multi-cellular models and simulations with EPISIM and COPASI , 2013, Bioinform..

[43]  A. Brú,et al.  Fractal analysis and tumour growth , 2008, Math. Comput. Model..

[44]  M. Nowak,et al.  Dynamics of cancer progression , 2004, Nature Reviews Cancer.

[45]  Alessandra Cucina,et al.  A systems biology approach to cancer: fractals, attractors, and nonlinear dynamics. , 2011, Omics : a journal of integrative biology.

[46]  T. Vincent,et al.  An evolutionary model of carcinogenesis. , 2003, Cancer research.

[47]  M. Selbach,et al.  Global analysis of cellular protein translation by pulsed SILAC , 2009, Proteomics.

[48]  W. Ye,et al.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. , 2012, Cancer research.

[49]  S. Kauffman,et al.  Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. , 2009, Seminars in cell & developmental biology.

[50]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[51]  L A Aguirre,et al.  What can be learned from a chaotic cancer model? , 2013, Journal of theoretical biology.

[52]  B. Pützer,et al.  E2F1 in melanoma progression and metastasis. , 2010, Journal of the National Cancer Institute.

[53]  H. Kitano Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.

[54]  Stephanie Forrest,et al.  Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  B. Timmermann,et al.  The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations , 2011, Cancer and Metastasis Reviews.

[56]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[57]  Birgit Schoeberl,et al.  An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. , 2010, Cancer cell.